文献速递儿童血液肿瘤与免疫儿童心血管与肾脏

儿童医院获得性血栓风险模型开发:儿童医院获得性血栓联盟报告

Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium.
PubMed 文献 · J Pediatr · 2020-09-10

基于儿童医院获得性血栓登记处728例HA-VTE病例和839例非VTE对照,采用加权logistic回归与Lasso方法,利用入院当天可识别的临床变量构建HA-VTE风险模型,内部5折交叉验证显示AUC为0.78(95%CI 0.76-0.80)。

要点

  • 模型纳入年龄<1岁和10-22岁、癌症、先天性心脏病、中心静脉导管、近期手术等入院时可识别因素。
  • 内部验证AUC为0.78(95%CI 0.76-0.80),判别能力中等。
  • 该模型需外部验证后,方可用于识别低风险及最高风险住院儿童,以指导未来预防策略临床试验。

核心结论

  • 基于入院当天可识别临床变量构建的儿童HA-VTE风险模型,内部验证AUC为0.78(95%CI 0.76-0.80)。
  • 该模型需外部验证后,方可用于识别低风险及最高风险住院儿童,以指导未来预防策略临床试验。

研究设计与样本

  • 儿童医院获得性血栓登记处为多机构注册研究,纳入0-21岁住院诊断为HA-VTE的病例及非VTE对照。
  • 采用加权logistic回归和Lasso方法,基于入院时存在的人口学与临床VTE危险因素构建风险模型。
  • 模型采用5折交叉验证进行内部验证,并以ROC曲线下面积评估判别能力、Hosmer-Lemeshow拟合优度评估校准度。

主要发现

  • 共提取728例HA-VTE病例和839例非VTE对照的临床数据,入院时间在2012年1月至2016年12月之间。
  • 模型中有统计学意义的要素包括年龄<1岁和10-22岁、癌症、先天性心脏病、其他高危状况、近期住院、制动、血小板计数>350 K/μL、中心静脉导管、近期手术、类固醇及机械通气。
  • 模型ROC曲线下面积为0.78(95%CI 0.76-0.80)。

关键数值与推荐

  • 模型中有统计学意义的要素包括年龄<1岁和10-22岁、癌症、先天性心脏病、其他高危状况(炎症/自身免疫病、血液相关疾病、蛋白丢失状态、全肠外营养依赖、血栓形成倾向/个人VTE史)、近期住院、制动、血小板计数>350 K/μL、中心静脉导管、近期手术、类固醇及机械通气。
  • 模型判别能力以ROC曲线下面积0.78(95%CI 0.76-0.80)表示。
  • 模型校准度采用Hosmer-Lemeshow拟合优度评估。

临床怎么用

  • 该模型尚需外部验证,暂不能直接用于临床风险分层或预防决策。
  • 外部验证后可用于识别低风险及最高风险住院儿童,为未来预防策略临床试验筛选人群。

局限性

  • 模型仅在儿童医院获得性血栓登记处数据中完成内部验证(5折交叉验证),尚未进行外部验证。
  • 原文未报告模型校准度的具体数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify pertinent clinical variables discernible on the day of hospital admission that can be used to assess risk for hospital-acquired venous thromboembolism (HA-VTE) in children. STUDY DESIGN: The Children's Hospital-Acquired Thrombosis Registry is a multi-institutional registry for all hospitalized participants aged 0-21 years diagnosed with a HA-VTE and non-VTE controls. A risk assessment model (RAM) for the development of HA-VTE using demographic and clinical VTE risk factors present at hospital admission was derived using weighted logistic regression and the least absolute shrinkage and selection (Lasso) procedure. The models were internally validated using 5-fold cross-validation. Discrimination and calibration were assessed using area under the receiver operating characteristic curve and Hosmer-Lemeshow goodness of fit, respectively. RESULTS: Clinical data from 728 cases with HA-VTE and 839 non-VTE controls, admitted between January 2012 and December 2016, were abstracted. Statistically significant RAM elements included age <1 year and 10-22 years, cancer, congenital heart disease, other high-risk conditions (inflammatory/autoimmune disease, blood-related disorder, protein-losing state, total parental nutrition dependence, thrombophilia/personal history of VTE), recent hospitalization, immobility, platelet count >350 K/μL, central venous catheter, recent surgery, steroids, and mechanical ventilation. The area under the receiver operating characteristic curve was 0.78 (95% CI 0.76-0.80). CONCLUSIONS: Once externally validated, this RAM will identify those who are at low-risk as well as the greatest-risk groups of hospitalized children for investigation of prophylactic strategies in future clinical trials.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Jaffray J, Branchford B, Goldenberg N, et al. Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium. J Pediatr. 2020. PMID: 32920105. doi:10.1016/j.jpeds.2020.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。